The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial (1995) Diabetes, 44, pp. 968-983
Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) Lancet, 352, pp. 837-853
Recommandations de l'ANAES : Suivi du patient diabétique de type 2 à 1'exclusion du suivi des complications (1999) Diabetes & Metabolism, 25 (2 SUPPL.)
Gillery, P., Labbé, D., Dumont, G., Vassault, A., Glycohemoglobin assays evaluated in a large-scale quality control survey (1995) Clin Chem, 41, pp. 1644-1648
Gillery, P., Dumont, G., Vassault, A., Evaluation of glycohemoglobin assays in France by national quality control surveys (1998) Diabetes Care, 21, pp. 265-270
Gillery, P., Bordas-Fonfrède, M., Chapelle, J.P., Hue, G., Périer, C., Hémoglobine glyquée : Le temps de la standardistion est venu (1998) Ann Biol Clin, 56, pp. 249-251
Gillery, P., Bordas-Fonfrède, M., Chapelle, J.P., HbA1c: Concertation clinico-biologique pour la standardisation des méthodes de dosage (1999) Diabetes Metab, 25, pp. 283-287
Goudable, J., Aulois-Griot, M., Billion, P., Recommandations concernant la biologie délocalisée (1998) Ann Biol Clin, 56, pp. 114-115
Sachs, C., Les véritables enjeux de la biologie délocalisée : Méthodologie d'avenir, mode passagère ou tout simplement escroquerie ? (2000) Ann Biol Clin, 58, pp. 261-266
Tormey, W.P., Hickey, D.P., An urgent use for hemoglobin A1c ? (1997) Clin Chem, 43, pp. 1463-1464
Guerci, B., Durain, D., Leblanc, H., Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin (1997) Diabetes Metab, 23, pp. 195-201
Frantzen, F., Grimsrud, K., Heggli, D.E., Faaren, A.L., Løvli, T., Sundrehagen, E., Glycohemoglobin filter assay for doctors'offices based on boronic acid affinity principle (1997) Clin Chem, 43, pp. 2390-2396
Gillery, P., Hue, G., Bordas-Fonfrède, M., Dosage de l'hémoglobine A1c et hémoglobinopathies : Problèmes posés et conduite à tenir (2000) Ann Biol Clin, 58, pp. 425-430
Le Floch, J.P., Vesco, L., Thomas, J., Capillary glycated hemoglobin and improved metabolic control in insulin-treated diabetic patients (1997) Diabetologia, 40 (1 SUPPL.), p. 327
Cagliero, E., Levina, E.V., Nathan, D.M., Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients (1999) Diabetes Care, 22, pp. 1785-1789
Thaler, L.M., Ziemer, D.C., Gallina, D.L., Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making (1999) Diabetes Care, 22, pp. 1415-1421
Carter, J.S., Houston, C.A., Gilliland, S.S., Rapid HbA1c testing in a community setting (1996) Diabetes Care, 19, pp. 764-767
Reach, G., Slama, G., Conséquences possibles sur le suivi des patients diabétiques de type 2 d'une modification récente d'une méthode de dosage de l'hémoglobine glyquée (1999) Diabetes Metab, 25, pp. 432-435
Marrero, G., Vandagriff, J.L., Gibson, R., Fineberg, S.E., Fineberg, N.S., Hiar, C.E., Crowler, L.E., Immediate HbA1c results. Performance of new HbA1c system in pediatric outpatient population (1992) Diabetes Care, 15, pp. 1045-1049
Guthrie, R., Hellman, R., Kilo, C., A multisite physician's office laboratory evaluation of an immunological method for the measurement of HbA1c (1992) Diabetes, 15, pp. 1494-1498
Richard, J.M., Vannereau, D., Lalloyer, N., Evaluation d'une méthode rapide de dosage de l'HbA1c par immuno-agglutination (DCA 2000) en pratique diabétologique (1995) Diabétologie et facteurs de risque, 1, pp. 27-29
Le Marois, E., Bruzzo, F., Reach, G., Comparison between a rapid glycohaemoglobin (HbA1c) immunoassay and other indices of glycaemic control (1996) Acta Diabetol, 33, pp. 232-235
Fonfrède, M., Grimaldi, A., Evaluation of the DCA 2000 system for glycated haemoglobin measurement (1998) Diabetes Metab, 24, pp. 66-67